A recent blog from Nature highlights some of the current issues facing successful clinical-trial data sharing, including resource shortages, insufficient government regulation and incompatible reporting. Vivli, a new data sharing … Continue Reading The road to successful data sharing
The registration of clinical trials on public platforms such as clinicaltrials.gov has become commonplace in recent years and is now a prerequisite for the publication of clinical data in many … Continue Reading Access all publications related to a clinical trial at a click of a button
Data sharing must become routine argue Richard Smith and Ian Roberts in a recent opinion article published on F1000Research. They acknowledge that researchers are incentivised to publish papers rather than … Continue Reading Why do researchers refuse to share their data?
In a recent article published in Research Integrity and Peer Review, Dunn et al argue the benefits of having a fully-accessible, central database for researcher conflicts of interest. While improvements … Continue Reading Researchers argue for a central conflicts of interest database
Over 500 journals have endorsed the Transparency and Openness Promotion (TOP) guidelines, a new scheme aiming to improve the transparency and reproducibility of published research. The guidelines consist of eight … Continue Reading How to simplify manuscript submission
As a prerequisite for publication of research, the International Committee of Medical Journal Editors (ICMJE) requires registration of clinical trials and recommends this to editors of medical journals. Similarly, provision … Continue Reading Retrospective vs. prospective registration of clinical trials – what is the norm?
In a recent blog Dr Ben Goldacre, from Oxford University DataLab, describes the concept of OpenTrials, an open platform for locating and sharing all freely available data and documents from … Continue Reading OpenTrials: all clinical trial data in one place
In a recent article published by the Journal of the American Medical Association (JAMA) Bauchner et al, reflect on the ethical obligations and scientific necessity of clinical trial data sharing. … Continue Reading The ethical obligation of data sharing
Following the publication of a controversial editorial in the New England Journal of Medicine, the Health Affairs Blog recently took a closer look at the risks and benefits of sharing … Continue Reading How do we ensure that data sharing benefits all?
Clinical trials with negative results have traditionally been viewed as ‘failures’. However, in the current age of transparency, there is a strong movement to ensure that all data, positive or negative … Continue Reading Phase III cancer clinical trials: the positive side of negative results
On February 29th 2016, the 15th Annual International Publication Planning Association (TIPPA) meeting convened for two days in San Diego, CA to discuss the evolving challenges impacting on the publications community. … Continue Reading Meeting report: Summary of Day 2 of the 2016 TIPPA Meeting
On February 29th 2016, the 15th Annual International Publication Planning Association (TIPPA) meeting convened in San Diego, CA for two days to discuss the evolving challenges impacting on the publications community. The … Continue Reading Meeting report: Summary of Day 1 of the 2016 TIPPA Meeting
It is established best-practice that all clinical trial outcomes should be pre-specified in a trial protocol and on a clinical trial registry and then reported once the trial is complete. … Continue Reading Fixing the problem of outcome-switching in clinical trials
The next COPE (Committee on Publication Ethics) forum is on Friday 12th February 2016, when the subject of data sharing will be discussed. Data sharing, as an indication of improving … Continue Reading Data sharing and transparency – COPE would like your views?
In general, scientists laud the concept of transparency and data sharing but a recent article “Don’t let transparency ruin science” by Stephan Lewandowsky and Dorothy Bishop highlights that care is … Continue Reading Harassment – a potential unwelcome consequence of transparency?
Data transparency is a hot topic at the moment and there are many different views, not only on the best way to proceed, but also on the advantages and disadvantages … Continue Reading Individual patient data sharing – have we considered all angles?